Effect of Transumbilical Laparoendoscopic Single-Site Surgery with Extracorporeal Approach for Benign Ovarian Cysts

To determine the clinical effect of transumbilical laparoendoscopic single-site surgery (TU-LESS) combined with extracorporeal operation mode in the treatment of noncancerous ovarian cysts.

Observational study. Place and Duration of the Study: Department of Gynaecology, Maternity and Child Health Centre of Qinhuangdao, Qinhuangdao, China, from December 2022 to September 2024.

A total of sixty patients undergoing cystectomy were subjected to either the TU-LESS with extracorporeal technique (n = 30) or the multi-port laparoscopic surgery (MPLS) (n = 30). Surgical parameters, inflammatory markers (SAA, CRP, and IL-6), recovery indices, and satisfaction were retrospectively compared using t-test or χ² test.

No significant differences were found in operative duration, blood loss, and complications (p >0.05). The observation group had an earlier postoperative anal exhaust time, a shorter hospital stay, and a reduced incision pain score 24 hours after surgery compared to the comparison group (p <0.05). Inflammatory cytokine concentrations were decreased in the observation group compared to the comparison group (p <0.05). Patient satisfaction regarding surgical incisions was significantly higher in the observation group than in the comparison group (p <0.05).

Compared to the conventional MPLS, TU-LESS with extracorporeal cystectomy accelerates recovery, reduces inflammation, and improves patient satisfaction.

Transumbilical laparoendoscopic single-site surgery, Multi-port laparoscopic surgery, Non-cancerous ovarian cyst, Perioperative outcome.